As genome editing moves from the lab into the clinic, the ethical debate can no longer be hypothetical By Karen Yeung and Peter Mills

Genome editing is beginning to move from the laboratory into the clinic. A number of clinical trials are in progress, using genome-edited cells to treat disease in patients.But it is the prospect of heritable genome editing, in order to influence the characteristics of a future person, and in turn, those that may come after them, that has attracted the greatest attention and contestation.

Read more in weforum